However, if these experiences do not go away over a few weeks, please consult your health care provider as you may have a sleep disorder or medical condition other than insomnia. In the early stages of treatment, increased daytime sleepiness may be expected, but is usually temporary.
Somryst contains sensitive medical information about you.Somryst is not meant to be a substitution for any treatment medication.Somryst is not meant to be used as treatment except under supervision of your Health Care Provider.Do not use Somryst to communicate severe or urgent information to your Health Care Provider.Please dial 911 or go to the nearest emergency room in the event of a medical emergency. You and your Health Care Provider should discuss whether Somryst is right for you. If you are unsure whether you have any of the conditions or disorders listed, speak with your Health Care Provider. If you have any other unstable or degenerative illness judged to be worsened by sleep restriction delivered as part of Cognitive Behavioral Therapy for Insomnia.bipolar disorder, schizophrenia, other psychotic spectrum disorders) Any disorder worsened by sleep restriction (e.g.If you have any of the following conditions or disorders, you should not use Somryst:
Because of this, it is not appropriate for everyone. Sleep restriction and consolidation may worsen preexisting medical conditions. Somryst uses sleep restriction and consolidation, limiting the time you spend in bed to match the amount of time you sleep.
#Insomnia cookie coupon code february 2017 how to#
Are familiar with how to use mobile apps (applications).Have regular access to a mobile device (such as smartphone or tablet).Are able to read and understand English.Somryst treats patients with chronic insomnia by improving a patient’s insomnia symptoms. Somryst® is a prescription-only digital therapeutic intended to provide a neurobehavioral intervention (CBT-I) to patients 22 years of age and older with chronic insomnia. and Canada calls) or 714.252.6860 (for tolled international calls) or via email at for Use We will attempt to keep our products available for patients who are already using the products for the duration of the current fill of their prescription, but there can be no assurance that we will be able to do so.Īdditional information about the Company’s Chapter 11 case may be found on both the Company’s website, or the website of the Company’s Bankruptcy Claims and Noticing Agent, Stretto, at or by calling Stretto’s hotline at 855.944.1910 (for toll-free U.S.
Pear Therapeutics is not accepting new prescriptions for its products, reSET ®, reSET-O ®, and Somryst ®, nor will refills be dispensed at this time. Our hope is that our business and/or products will be purchased so that another company can provide them to patients. The Debtors intend to pursue a sale of the business or assets under section 363 of the Bankruptcy Code. (collectively, the “Debtors”) each voluntarily filed for Chapter 11 bankruptcy protection in the United States Bankruptcy Court for the District of Delaware (Case Nos. and its wholly owned subsidiary, Pear Therapeutics (US), Inc.
0 kommentar(er)
